$CDZI
CADIZ INC

2021 Q3 Form 10-Q Financial Statement

#000143774921019806 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $142.0K $141.0K $148.0K
YoY Change 2.16% -4.73% 33.33%
Cost Of Revenue $0.00
YoY Change
Gross Profit $142.0K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $4.202M $6.375M $3.100M
YoY Change 66.09% 105.65% -5.78%
% of Gross Profit 2959.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $107.0K $106.0K $100.0K
YoY Change 7.0% 6.0% 66.67%
% of Gross Profit 75.35%
Operating Expenses $4.309M $6.478M $3.190M
YoY Change 63.84% 103.07% -4.78%
Operating Profit -$4.167M -$6.337M -$3.046M
YoY Change 67.08% 108.04% -5.99%
Interest Expense $2.000M $4.858M $1.674M
YoY Change 4.17% 190.2% -61.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$7.566M -$11.20M -$4.719M
YoY Change 71.41% 137.23% -36.86%
Income Tax $2.000K $1.000K $1.000K
% Of Pretax Income
Net Earnings -$7.839M -$11.56M -$4.793M
YoY Change 74.47% 141.23% -35.89%
Net Earnings / Revenue -5520.42% -8200.0% -3238.51%
Basic Earnings Per Share -$0.22 -$0.30
Diluted Earnings Per Share -$187.3K -$295.7K -$137.6K
COMMON SHARES
Basic Shares Outstanding 41.29M 39.10M 34.80M
Diluted Shares Outstanding 34.80K

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.58M $11.19M $5.600M
YoY Change 147.67% 99.75% -71.28%
Cash & Equivalents $18.58M $11.19M $5.568M
Short-Term Investments
Other Short-Term Assets $2.186M $1.235M $600.0K
YoY Change 264.33% 105.83% 0.0%
Inventory
Prepaid Expenses
Receivables $83.00K $66.00K $138.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.84M $12.49M $6.335M
YoY Change 153.18% 97.11% -68.58%
LONG-TERM ASSETS
Property, Plant & Equipment $77.58M $76.10M $52.45M
YoY Change 47.26% 45.1% 10.75%
Goodwill $3.813M $3.813M $3.813M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $949.0K $1.044M $1.998M
YoY Change -59.57% -47.75%
Other Assets $4.324M $4.487M $4.339M
YoY Change 0.58% 3.41% 3.41%
Total Long-Term Assets $99.26M $89.16M $64.60M
YoY Change 52.38% 38.02% 12.61%
TOTAL ASSETS
Total Short-Term Assets $20.84M $12.49M $6.335M
Total Long-Term Assets $99.26M $89.16M $64.60M
Total Assets $120.1M $101.6M $70.93M
YoY Change 63.69% 43.3% -8.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $579.0K $117.0K $1.075M
YoY Change 32.19% -89.12% -1.01%
Accrued Expenses $2.481M $2.156M $1.026M
YoY Change 187.49% 110.14% -25.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $134.0K $43.00K $17.00K
YoY Change 148.15% 152.94% -67.92%
Total Short-Term Liabilities $4.667M $2.341M $4.190M
YoY Change 50.16% -44.13% 20.61%
LONG-TERM LIABILITIES
Long-Term Debt $45.93M $82.48M $73.74M
YoY Change -38.94% 11.85% -46.56%
Other Long-Term Liabilities $31.00K $31.00K $2.000K
YoY Change 1450.0% -99.99%
Total Long-Term Liabilities $45.96M $82.51M $73.74M
YoY Change -38.9% 11.89% -46.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.667M $2.341M $4.190M
Total Long-Term Liabilities $45.96M $82.51M $73.74M
Total Liabilities $72.99M $106.7M $95.11M
YoY Change -23.88% 12.19% -39.53%
SHAREHOLDERS EQUITY
Retained Earnings -$566.2M -$556.9M -$526.9M
YoY Change 6.55% 5.7% 8.24%
Common Stock $424.0K $405.0K $347.0K
YoY Change 20.11% 16.71% 29.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.12M -$5.065K -$24.18M
YoY Change
Total Liabilities & Shareholders Equity $120.1M $101.6M $70.93M
YoY Change 63.69% 43.3% -8.51%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$7.839M -$11.56M -$4.793M
YoY Change 74.47% 141.23% -35.89%
Depreciation, Depletion And Amortization $107.0K $106.0K $100.0K
YoY Change 7.0% 6.0% 66.67%
Cash From Operating Activities -$3.644M -$3.179M -$2.640M
YoY Change 11.1% 20.42% -6.71%
INVESTING ACTIVITIES
Capital Expenditures -$917.0K -$19.67M -$1.260M
YoY Change 135.13% 1460.87% 93.85%
Acquisitions
YoY Change
Other Investing Activities -$176.0K -$119.0K -$1.040M
YoY Change -59.07% -88.56%
Cash From Investing Activities -$1.093M -$19.79M -$2.310M
YoY Change 34.94% 756.54% 255.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.33M 15.48M -10.00K
YoY Change 270.35% -154910.0% -100.15%
NET CHANGE
Cash From Operating Activities -3.644M -3.179M -2.640M
Cash From Investing Activities -1.093M -19.79M -2.310M
Cash From Financing Activities 22.33M 15.48M -10.00K
Net Change In Cash 17.59M -7.484M -4.960M
YoY Change 806.96% 50.89% -252.62%
FREE CASH FLOW
Cash From Operating Activities -$3.644M -$3.179M -$2.640M
Capital Expenditures -$917.0K -$19.67M -$1.260M
Free Cash Flow -$2.727M $16.49M -$1.380M
YoY Change -5.64% -1294.78% -36.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41291227
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6281
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6281
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7531
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7531
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40618400
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40618400
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36902361
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36902361
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 USD
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P29Y
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6281
CY2021Q2 us-gaap Revenues
Revenues
141000 USD
CY2020Q2 us-gaap Revenues
Revenues
148000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6375000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3098000 USD
CY2021Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
103000 USD
CY2020Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
96000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
6478000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
3194000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6337000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3046000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
4858000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
1674000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11195000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4719000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-366000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-73000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-11562000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4793000 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39099
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34798
us-gaap Revenues
Revenues
280000 USD
us-gaap Revenues
Revenues
262000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9608000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7075000 USD
us-gaap Depreciation Nonproduction
DepreciationNonproduction
206000 USD
us-gaap Depreciation Nonproduction
DepreciationNonproduction
175000 USD
us-gaap Costs And Expenses
CostsAndExpenses
9814000 USD
us-gaap Costs And Expenses
CostsAndExpenses
7250000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9534000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6988000 USD
us-gaap Interest Expense
InterestExpense
7400000 USD
us-gaap Interest Expense
InterestExpense
5246000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
23000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12394000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16934000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24605000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-569000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-699000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17506000 USD
us-gaap Net Income Loss
NetIncomeLoss
-25307000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.77
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38470
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32955
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11186000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7290000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1235000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
691000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
12487000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8036000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76098000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53481000 USD
CY2021Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 USD
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
3000000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1044000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1354000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
3813000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
3813000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3294000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4487000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4664000 USD
CY2021Q2 us-gaap Assets
Assets
101643000 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3109000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2021Q2 us-gaap Liabilities
Liabilities
106708000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
99664000 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2020Q4 us-gaap Assets
Assets
74363000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
117000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
548000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2156000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
674000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
43000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
51000 USD
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1847000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
25000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2341000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3135000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
82476000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78596000 USD
CY2021Q2 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
18001000 USD
CY2020Q4 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
17183000 USD
CY2021Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
405000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
368000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
551449000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
513744000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-556920000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-539414000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5065000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25301000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101643000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74363000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17506000 USD
us-gaap Net Income Loss
NetIncomeLoss
-25307000 USD
us-gaap Depreciation
Depreciation
206000 USD
us-gaap Depreciation
Depreciation
175000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2372000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
587000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
4209000 USD
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
3331000 USD
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
806000 USD
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
712000 USD
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-569000 USD
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-699000 USD
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-0 USD
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-12394000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3440000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1551000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
51000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
89000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
544000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
243000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-177000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
243000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-154000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
879000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-175000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1170000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1516000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5999000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7019000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20177000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4712000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
259000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2283000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20436000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6995000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30354000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3923000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
23000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30331000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3900000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3896000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10114000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15816000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11320000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5702000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25301000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
148000 USD
CY2021Q1 cdzi Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
3179000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5944000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-13052000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3293000 USD
CY2021Q2 cdzi Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
4000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-11562000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5065000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-82118000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
38900000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1251000 USD
CY2020Q1 cdzi Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
-865000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20514000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-19687000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
300000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4793000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-24180000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17500000 USD
us-gaap Net Income Loss
NetIncomeLoss
-25300000 USD
CY2021Q2 cdzi Working Capital
WorkingCapital
10100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6000000.0 USD
us-gaap Interest Paid Net
InterestPaidNet
819000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11186000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7290000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5568000 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11320000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5702000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
CY2021Q2 cdzi Debt Instrument Extension Option Fee Percentage
DebtInstrumentExtensionOptionFeePercentage
0.01 pure
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83368000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60545000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7270000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7064000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76098000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53481000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q2 cdzi Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer
WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer
9500 pure
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3440000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1551000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1200000 USD
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3196000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4626000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2903000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3153000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3300000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
174000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
322000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
321000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
321000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
321000 USD
CY2021Q2 cdzi Lessee Operating Lease Liability Payments Due After Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFour
7692000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8977000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5843000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3134000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6281

Files In Submission

Name View Source Status
0001437749-21-019806-index-headers.html Edgar Link pending
0001437749-21-019806-index.html Edgar Link pending
0001437749-21-019806.txt Edgar Link pending
0001437749-21-019806-xbrl.zip Edgar Link pending
cdzi-20210630.xsd Edgar Link pending
cdzi-20210630_cal.xml Edgar Link unprocessable
cdzi-20210630_def.xml Edgar Link unprocessable
cdzi-20210630_lab.xml Edgar Link unprocessable
cdzi-20210630_pre.xml Edgar Link unprocessable
cdzi20210630_10q.htm Edgar Link pending
cdzi20210630_10q_htm.xml Edgar Link completed
ex_274767.htm Edgar Link pending
ex_274768.htm Edgar Link pending
ex_274769.htm Edgar Link pending
ex_274770.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending